Renaissance Technologies’s Kindred Biosciences, Inc. KIN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,321,859
Closed -$12.1M 4030
2021
Q2
$12.1M Sell
1,321,859
-95,000
-7% -$871K 0.02% 1045
2021
Q1
$7.04M Sell
1,416,859
-173,000
-11% -$860K 0.01% 1438
2020
Q4
$6.85M Buy
1,589,859
+38,161
+2% +$164K 0.01% 1398
2020
Q3
$6.66M Buy
1,551,698
+167,189
+12% +$717K 0.01% 1400
2020
Q2
$6.22M Buy
1,384,509
+201,611
+17% +$905K 0.01% 1507
2020
Q1
$4.73M Buy
1,182,898
+3,600
+0.3% +$14.4K ﹤0.01% 1602
2019
Q4
$10M Sell
1,179,298
-26,400
-2% -$224K 0.01% 1447
2019
Q3
$8.26M Buy
1,205,698
+19,200
+2% +$132K 0.01% 1509
2019
Q2
$9.88M Sell
1,186,498
-35,900
-3% -$299K 0.01% 1426
2019
Q1
$11.2M Buy
1,222,398
+123,810
+11% +$1.14M 0.01% 1311
2018
Q4
$12M Buy
1,098,588
+44,788
+4% +$490K 0.01% 1192
2018
Q3
$14.7M Buy
1,053,800
+105,100
+11% +$1.47M 0.02% 1113
2018
Q2
$10.1M Buy
948,700
+253,500
+36% +$2.7M 0.01% 1339
2018
Q1
$6.01M Sell
695,200
-31,863
-4% -$276K 0.01% 1701
2017
Q4
$6.87M Sell
727,063
-99,737
-12% -$943K 0.01% 1611
2017
Q3
$6.49M Buy
826,800
+10,200
+1% +$80.1K 0.01% 1592
2017
Q2
$7.02M Buy
816,600
+311,800
+62% +$2.68M 0.01% 1483
2017
Q1
$3.56M Buy
504,800
+153,200
+44% +$1.08M 0.01% 1911
2016
Q4
$1.49M Buy
351,600
+20,000
+6% +$85K ﹤0.01% 2369
2016
Q3
$1.66M Buy
331,600
+28,900
+10% +$144K ﹤0.01% 2303
2016
Q2
$1.07M Buy
302,700
+84,800
+39% +$300K ﹤0.01% 2497
2016
Q1
$752K Sell
217,900
-48,002
-18% -$166K ﹤0.01% 2710
2015
Q4
$904K Buy
265,902
+146,092
+122% +$497K ﹤0.01% 2507
2015
Q3
$623K Sell
119,810
-58,045
-33% -$302K ﹤0.01% 2558
2015
Q2
$1.21M Buy
177,855
+63,155
+55% +$431K ﹤0.01% 2349
2015
Q1
$819K Buy
114,700
+94,300
+462% +$673K ﹤0.01% 2406
2014
Q4
$152K Buy
+20,400
New +$152K ﹤0.01% 2732